Prenatal opioid use is associated with increased maternal and infant mortality, prematurity, and poor neonatal outcomes.
In a cohort of 351 children exposed to second generation antipsychotic during pregnancy, the risk of major congenital malformations did not differ from a comparison group of non-exposed children.
Changes in maternal sleep and circadian rhythms during pregnancy are associated with infant sleep problems and maternal depression and anxiety.
Risk of PPD is low in women who successfully conceive.
Every week we review the most recent publications in women’s mental health.
Zuranolone has antidepressant effects in women with severe PPD, observed as early as 3 days after initiation of treatment.
There is no easy way to talk to children about the tragic events in Uvalde Texas. Here are some resources for parents and caregivers.
Cannabis use, as well as use of benzodiazepines and sedative-hypnotic medications, was more common in women with depression.
Second-generation antipsychotic medications associated with high metabolic risk (quetiapine, olanzapine, and clozapine) were associated with increased risk of gestational diabetes; other antipsychotics were not.
Our data regarding prenatal exposure to BZDs and/or z-drugs and risk of neurodevelopmental outcomes is still sparse.
